GlaxoSmithKline Pays Billions for New Cancer Immunotherapy

The British pharmaceutical company GlaxoSmithKline forges a billion-dollar alliance with the US biotech company iTeos to develop a new cancer immunotherapy. In the course of the partnership, iTeos can hope…

Read More

Page 1 of 1